Personalis And 2 Other AI Healthcare Stocks To Watch

Simply Wall St.11-07

Big Tech companies have been raising record amounts in the bond market this year to fund heavier spending on AI, even as borrowing costs rise and investors question how quickly those projects will pay...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2681089793?lang=en_US&edition=fundamental","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/9551728-choice1-card/1788934355557","is_english":true,"pubTime":"2026-11-07 06:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2681089793","market":"sg","top_or_hot":-1,"title":"Personalis And 2 Other AI Healthcare Stocks To Watch","media":"Simply Wall St.","content":"<div>\n<p>Big Tech companies have been raising record amounts in the bond market this year to fund heavier spending on AI, even as borrowing costs rise and investors question how quickly those projects will pay...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/personalis-and-2-other-ai-healthcare-stocks-to-watch\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Personalis And 2 Other AI Healthcare Stocks To Watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPersonalis And 2 Other AI Healthcare Stocks To Watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-11-07 06:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/personalis-and-2-other-ai-healthcare-stocks-to-watch><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Big Tech companies have been raising record amounts in the bond market this year to fund heavier spending on AI, even as borrowing costs rise and investors question how quickly those projects will pay...</p>\n\n<a href=\"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/personalis-and-2-other-ai-healthcare-stocks-to-watch\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARTY","symbol_name":"ISHARES FUTURE AI & TECH ETF","start_time":0,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/personalis-and-2-other-ai-healthcare-stocks-to-watch","article_id":"2681089793","we_media_id":null,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/9551728-choice1-card/1788934355557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-psnl/personalis/news/personalis-and-2-other-ai-healthcare-stocks-to-watch","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2681089793","pubTimestamp":1794003685,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"BBailey PembertonNovember 6, 2026","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARTY":"ISHARES FUTURE AI & TECH ETF","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","IE00BFXG0V08.USD":"BNY MELLON GLOBAL LEADERS \"B\" (USD) ACC","LU0347712357.USD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (USD) ACC","AGIX":"通用人工智能 ETF-AGIX","LU2413666426.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"C\" (HKD) ACC","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","PSNL":"Personalis","QTOC":"Innovator Growth Accelerated Plus ETF - October","XBI":"SPDR S&P Biotech ETF","BK4588":"碎股","LU2211817866.USD":"Allianz Food Security AT Acc USD","VTHR":"Vanguard Russell 3000 ETF","HCSG":"Healthcare Svcs Group Inc","BK4548":"巴美列捷福持仓","INSM":"Insmed","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","XLV":"健康照护类股ETF-SPDR","IE00B5TLWC47.USD":"BNY MELLON LONG-TERM GLOBAL EQUITY \"B\" (USD) ACC","VGT":"信息技术ETF-Vanguard","IE00BYQQ9H92.USD":"BNY MELLON GLOBAL LEADERS \"A\" (USD) ACC","LU2413666699.HKD":"BNP PARIBAS GLOBAL ENVIRONMENT \"CRH\" (HKDHDG) INC","BK4137":"综合支持服务","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","BK4581":"高盛持仓","BK4121":"生命科学工具和服务","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","LABU":"三倍做多标普生物-Direxion","MTD":"梅特勒-托利多","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4139":"生物科技","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU1721428933.USD":"法巴全球经典环境基金RH MD Dis","BK4533":"AQR资本管理(全球第二大对冲基金)","AIPO":"Defiance AI and Power Infrastructure ETF"},"translate_title":"Personalis 和其他 2 只值得关注的人工智能医疗保健股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHAT":1.5,"AIPO":1.5,"VTHR":1.5,"HCSG":1.5,"QTOC":1.5,"ARTY":1.5,"XBI":0.6,"XLV":1.5,"AGIX":1.5,"LABU":0.6,"INSM":1,"PSNL":1.5,"MTD":1,"VGT":0.74},"content_text":"Big Tech companies have been raising record amounts in the bond market this year to fund heavier spending on AI, even as borrowing costs rise and investors question how quickly those projects will pay off. That tug of war between huge capital flows and nervous sentiment creates an opening. This article looks at three healthcare AI stocks that are using that same computing wave to try to solve real medical problems. The stocks below are a short sample of the theme. The full screen surfaced 31 more companies with equally compelling AI in healthcare stories that are not covered here. To identify your own highest conviction ideas in this space, head straight to the Transformative Artificial intelligence (AI) Healthcare Stocks screener. AdvertisementPersonalis (PSNL) Personalis uses high depth genomic sequencing plus AI driven analytics to help oncologists and drug developers detect residual cancer earlier and fine tune treatment decisions. This positions the company within the broader healthcare AI theme. Personalis, Inc. develops AI enabled cancer genomic tests like NeXT Personal and ImmunoID NeXT for MRD detection, tumor profiling and pharma research, and has a market cap of about US$1.69b. \"Expanding Medicare coverage for NeXT Personal in breast and lung cancer surveillance, along with active submissions for IO monitoring and neoadjuvant breast cancer, points to a larger pool of reimbursed tests that could lift clinical revenue and support margin recovery from current low levels.\"One relatively quiet shift in how these AI driven tests are paid for could potentially change the economics of Personalis much faster than currently anticipated. If that reimbursement shift feels underpriced, walk through the full narrative for Personalis to see how Personalis could accelerate or stall as those volumes and margins evolve. NasdaqGM:PSNL Revenue & Expenses Breakdown as at Nov 2026 Insmed (INSM) Insmed leans on a growing respiratory medicines franchise today, while its AI driven protein engineering work hints at a very different drug design toolkit tomorrow. This is why it earns a spot in an AI focused healthcare screen. \"Continued expansion of BRINSUPRI into the growing diagnosed U.S. bronchiectasis population of at least 500,000 patients, with company guidance for more than $1.25 to $1.4b in 2026 BRINSUPRI revenue and a raised peak sales view of more than $7b, points to further potential scaling of Insmed revenue and operating leverage.\"What happens to that operating leverage if a single assumption about how quickly new patients come onto treatment proves too optimistic? Insmed develops treatments for serious and rare diseases, with respiratory drugs like ARIKAYCE driving its US$1.52b in rare disease therapy revenue, and an AI driven protein engineering program targeting future medicines on top of a roughly US$23.9b market value. If that patient ramp risk is what you keep circling back to, read the full narrative for Insmed to see how Insmed’s AI work could accelerate or cushion the story. NasdaqGS:INSM Revenue & Expenses Breakdown as at Nov 2026 Mettler-Toledo International (MTD) Mettler-Toledo International leans heavily on precision instruments, but its LabX software and AI driven imaging tools quietly turn raw lab readings into cleaner, faster decisions for diagnostics and drug research, which is exactly why it earns a place in an AI healthcare screen. Mettler-Toledo International Inc. supplies precision instruments and lab software that support diagnostics, drug R&D and quality control, with AI linked LabX and imaging layered on top of a broad hardware base. Revenue is spread across U.S. Operations at about US$1.63b, Western European Operations at roughly US$1.14b, Swiss Operations at around US$1.08b, Chinese Operations near US$1.01b and Other Operations at about US$870 million. The group has a market value of roughly US$34.53b. \"Expanding bioprocessing and broader biopharma activity, including facility expansions, GLP‑1 manufacturing and reshoring related investments, is expected to create further demand for Mettler Toledo International’s process analytics and industrial equipment along the biopharma value chain.\" The real swing factor is how one pressure on future pricing power collides with that AI heavy lab workflow demand over the next few years. If that pricing pressure is what you keep coming back to, walk through the full narrative for Mettler-Toledo International for how Mettler-Toledo International could see AI demand and margins decoupling. NYSE:MTD Revenue & Expenses Breakdown as at Nov 2026 Seeking Alternatives Before They Take Off Fresh opportunities do not wait. By the time momentum headlines arrive, early entry points can be gone. Scan these under the radar ideas now, while it matters, and get in early.  Hunt for potential turnarounds with cleaner balance sheets and disciplined cash flows using the curated 42 high quality undervalued stocks before the crowd reacts to the next breakout wave. Target income ideas where yield and resilience intersect through a focused list of 6 dividend fortresses before prices move and yields start dropping. Track the infrastructure behind AI’s surge by reviewing carefully filtered 53 AI infrastructure stocks while these enablers of future capacity expansion remain under the radar.  This article is general in nature and was produced with the assistance of AI automation,\n        based on data and analysis from Simply Wall St. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2681089793","isCrawlerRequest":true}